Background and objective The long term effects of fingolimod, an oral treatment for relapsing-remitting (RR) multiple sclerosis (MS), on blood circulating B and T cell subtypes in MS patients are not
Additional file 3. List of differentially expressed proteins (fold change > 1.5, p < 0.05) in macrophage/monocyte, foam cell/ macrophage, and foam cell/monocyte.
There are 5 zip files: one each for the PhenoRipper models for 4 marker sets and one the profiles for all marker sets. After unzipping the contents of these zip files, please copy all .mat files into
